Strata Critical Medical, Inc. Cash Flow Conversion Efficiency
Strata Critical Medical, Inc. cash flow conversion efficiency. Based on the latest financial reports, Strata Critical Medical, Inc. (SRTA) has a cash flow conversion efficiency ratio of 0.012x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($3.56 Million) by net assets ($285.73 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Strata Critical Medical, Inc. (2019–2025)
Cash flow conversion efficiency of Strata Critical Medical, Inc. from 2019 to 2025. This chart illustrates how Strata Critical Medical, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View SRTA stock price and chart for real-time trading data and today's change.
Strata Critical Medical, Inc. Cash Flow Conversion Ratio Explained
Strata Critical Medical, Inc. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Strata Critical Medical, Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Strata Critical Medical, Inc. ranked by their cash flow conversion efficiency. Also see SRTA stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Anhui ANLI Artificial Leather
SHE:300218
|
0.036x |
|
Shandong Longji Machinery Co Ltd
SHE:002363
|
0.052x |
|
Long Chen Paper Co Ltd
TW:1909
|
0.044x |
|
Cantor Equity Partners III, Inc. Class A Ordinary Shares
NASDAQ:CAEP
|
N/A |
|
Clearfield Inc
NASDAQ:CLFD
|
0.040x |
|
Enseval Putra Megatrading Tbk
JK:EPMT
|
0.035x |
|
Promate Electronic Co Ltd
TW:6189
|
0.068x |
|
ABG Sundal Collier Holding ASA
OL:ABG
|
0.051x |
Annual Cash Flow Conversion Efficiency for Strata Critical Medical, Inc. (2019–2025)
The table below shows the annual cash flow conversion efficiency of Strata Critical Medical, Inc. from 2019 to 2025. Review Strata Critical Medical, Inc. (SRTA) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $279.07 Million | $-48.91 Million | -0.175x | -1444.26% |
| 2024-12-31 | $221.94 Million | $-2.52 Million | -0.011x | +91.78% |
| 2023-12-31 | $234.30 Million | $-32.35 Million | -0.138x | -2.07% |
| 2022-12-31 | $274.49 Million | $-37.13 Million | -0.135x | -152.41% |
| 2021-12-31 | $291.37 Million | $-15.62 Million | -0.054x | +94.51% |
| 2020-12-31 | $11.08 Million | $-10.82 Million | -0.976x | +52.61% |
| 2019-12-31 | $5.00 Million | $-10.30 Million | -2.060x | -- |
About Strata Critical Medical, Inc.
Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including … Read more